Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · IEX Real-Time Price · USD
4.930
-0.055 (-1.10%)
At close: Jul 2, 2024, 4:00 PM
5.06
+0.13 (2.64%)
After-hours: Jul 2, 2024, 7:41 PM EDT
Sensus Healthcare Revenue
Sensus Healthcare had revenue of $31.66M in the twelve months ending March 31, 2024, down -15.83% year-over-year. Revenue in the quarter ending March 31, 2024 was $10.66M with 212.33% year-over-year growth. In the year 2023, Sensus Healthcare had annual revenue of $24.41M, a decrease of -45.20%.
Revenue (ttm)
$31.66M
Revenue Growth
-15.83%
P/S Ratio
2.55
Revenue / Employee
$904,429
Employees
35
Market Cap
80.82M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 24.41M | -20.13M | -45.20% |
Dec 31, 2022 | 44.53M | 17.49M | 64.68% |
Dec 31, 2021 | 27.04M | 17.47M | 182.36% |
Dec 31, 2020 | 9.58M | -17.69M | -64.87% |
Dec 31, 2019 | 27.26M | 836.06K | 3.16% |
Dec 31, 2018 | 26.43M | 5.84M | 28.36% |
Dec 31, 2017 | 20.59M | 5.78M | 39.00% |
Dec 31, 2016 | 14.81M | 4.54M | 44.17% |
Dec 31, 2015 | 10.27M | 4.46M | 76.81% |
Dec 31, 2014 | 5.81M | -4.67M | -44.55% |
Dec 31, 2013 | 10.48M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aclaris Therapeutics | 31.12M |
DBV Technologies | 14.94M |
T2 Biosystems | 7.18M |
Affimed | 4.26M |
Ikena Oncology | 3.85M |
EUDA Health Holdings | 3.71M |
SRTS News
- 7 weeks ago - Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold - GlobeNewsWire
- 7 weeks ago - Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare's SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats - GlobeNewsWire
- 2 months ago - Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024 - GlobeNewsWire
- 3 months ago - Sensus Healthcare to Participate in the 36th Annual Roth Conference - GlobeNewsWire
- 3 months ago - Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 5 months ago - Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Sensus Healthcare Announces Retirement of Director Samuel O'Rear - GlobeNewsWire
- 5 months ago - Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024 - GlobeNewsWire